Institutional shared resources and translational cancer research

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL RESEARCH; CONFOCAL MICROSCOPY; COOPERATION; DISEASE MODEL; DRUG RESEARCH; EDUCATION PROGRAM; FINANCIAL MANAGEMENT; FLOW CYTOMETRY; GENE TECHNOLOGY; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; IMMUNE RESPONSE; INSTITUTIONAL CARE; INTERNET; NONHUMAN; ORGANIZATIONAL DEVELOPMENT; ORGANIZATIONAL EFFICIENCY; PROTEOMICS; RESOURCE MANAGEMENT; REVIEW; CLINICAL TRIAL (TOPIC); ECONOMICS; MEDICAL RESEARCH; NEOPLASM; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PERSONNEL; POLICY; PROGRAM DEVELOPMENT; RESEARCH; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ACADEMIES AND INSTITUTES; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; EFFICIENCY, ORGANIZATIONAL; FINANCING, GOVERNMENT; HUMANS; NEOPLASMS; ORGANIZATIONAL POLICY; PROGRAM DEVELOPMENT; RESEARCH; RESEARCH PERSONNEL; RESEARCH SUPPORT AS TOPIC;

EID: 67651102434     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-54     Document Type: Review

References (130)

1. Hait W Sustaining the clinical in clinical translational research Clin Cancer Res 2006, 12:1-2 16397015
2. Pober JS Neuhauser CS Pober JM Obstacles facing translational research in academic medical centers FASEB J 2001, 15:2303-2313 11689456
3. Slaughter C A bright but demanding future for core facilities J Biomol Tech 2005, 16:167-169 2291718 16030323
4. Angeletti RH Bonewald LF De Jongh K Niece R Rush J Stults J Research Technologies: Fulfilling the promise FASEB J 1999, 13:595-601 10094920
5. Howells J James A Malik K The sourcing of technological knowledge: distributed innovation processes and dynamic change R&D Management 2003, 4:395-409
6. Cogentech, Consortium for Genomic Technologies http://www.cogentech.it
7. CTSA West Coast Consortium. Shared resources for drug Discovery and Development http://ctsa.genomecenter.ucdavis.edu
8. National Center for Research Resources (NCRR) http://www.ncrr.nih.gov
9. The European Advanced Translational Research Infrastructure in Medicine http://www.eatris.eu
10. Berns KI Bond EC Manning F Resource Sharing in Biomedical Research Washington DC: National Academy of Sciences 1996
11. National Cancer Institutes Cancer Center Program http://cancercenters.cancer.gov/
12. Mestas J Hughes CC Of mice and not men: Differences between mouse and human immunology J Immunol 2004, 172:2731-2738 14978070
13. Schnabel J Neuroscience. Standard model Nature 2008, 45:682-685
14. Pierce MC Javier DJ Richards-Kortum R Optical contrast agents and imaging systems for detection and diagnosis of cancer Int J Cancer 2008, 123:1979-1990 18712733
15. Brown EB Campbell RB Tsuzuki Y Xu L Carmeliet P Fukumura D Jain RK In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy Nat Med 2001, 7:864-868 11433354
16. Kelloff GJ Sigman CC New science-based endpoints to accelerate oncology drug development Eur J Cancer 2005, 41:491-501 15737552
17. Ke S Wen X Gurfinkel M Charnsagavej C Wallace S Sevick-Muraca EM Li C Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts Cancer Res 2003, 63:7870-7875 14633715
18. Dominguez-Sola D Ying CY Grandori C Ruggiero L Chen B Li M Galloway DA Gu W Gautier J Dalla Favera R Non transcriptional control of DNA replication by c-myc Nature 2007, 448:445-451 17597761
19. Conchello JA Lichtman JW Optical sectioning microscopy Nat Methods 2005, 2:920-931 16299477
20. Mahnke YD Roederer M Optimizing a multicolor immunophenotyping assay Clin Lab Med 2007, 27:469-485 2034273 17658403
21. Perfetto SP Chattopadhyay P Rodererer M Seventeen-color flow cytometry: unravelling the immune system Nat Rev Immunol 2004, 4:648-655 15286731
22. Stacey DW Hitomi M Cell cycle studies based upon quantitative image analysis Cytometry A 2008, 73:270-278 18163464
23. Kutzik PO Irish JM Nolan GP Perez OD Analysis of protein phosphorylation and cellular signaling events by flow cytometry Clin Immunol 2004, 110:206-221 15047199
24. Schakney SE Shankey TV Common patterns of genetic evolution in solid tumors Cytometry 1997, 29:1-27 9298807
25. Irish JM Kotecha N Nolan GP Mapping normal and cancer cell signaling networks: Towards single-cell proteomics Nat Rev Cancer 2006, 6:146-155 16491074
26. Craig FE Foon KA Flow cytometric immunophenotyping for hematologic neoplasms Blood 2008, 111:3941-3967 18198345
27. Freeman SD Jovanovic JV Grimwade D Development of minimal residual disease-directed therapy in acute myeloid leukemia Semin Oncol 2008, 35:388-400 18692689
28. Kern F LiPira G Gratama JW Manca F Roederer M Measuring Ag specific immune responses: Understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer Trends Immunol 2005, 26:477-484 16039158
29. Sklar LA Carter MB Edwards BS Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening Curr Opin Pharmacol 2007, 7:527-534 2230635 17652026
30. Nolan JP Mandy F Multiplexed and microparticle-based analyses: quantitative tools for the large scale-analysis of biological systems Cytometry A 2006, 69:318-325 2200865 16604537
31. Sachdeva N Asthana D Cytokine quantitation: Technologies and applications Front Biosci 2007, 12:4682-4695 17485405
32. Lu J Getz G Miska A Alvarez-Saavedra E Lamb J Peck D Sweet-Cordero A Ebert B Mak R Ferrando A Downing J Jacks T Horviz R Golub T MicroRNA expression profiles classify human cancers Nature 2005, 435:834-838 15944708
33. Eisenstein M Cell sorting: Divide and conquer Nature 2006, 441:1179-1185 16810261
34. Ibrahim SF Engh van der G Flow cytometry and cell sorting Adv Biochem Eng Biotechnol 2007, 106:19-39 17728993
35. Johnson LA Welch GR Keyvanfar K Dorfmann A Fugger EF Schulman JD Gender preselection in humans? Flow cytometric separation of X and Y spermatozoa for the prevention of X-linked diseases Hum Reprod 1993, 8:1733-1739 8300839
36. Cram LS Bell CS Fawcett JJ Chromosome sorting and genetics Methods Cell Sci 2002, 24:27-35 12815287
37. Chung CH Levy S Chaurand P Carbone DP Genomics and proteomics: Emerging technologies in clinical cancer research Crit Rev Oncol Hematol 2007, 61:1-25 17015021
38. Quackenbush J Microarray analysis and tumor classification N Engl J Med 2006, 354:2463-2472 16760446
39. Rosenfeld N Aharonov R Meiri E Rosenwald S Spector Y Zepeniuk M Benjamin H Shabes N Tabak S Levy A Lebanony D Goren Y Silberschein E Targan N Ben-Ari A Gilad S Sion-Vardy N Tobar A Feinmesser M Kharenkoi O Nativ O Nass D Perelman M Yosepovich A Shalmon B Polak-Charcon S Fridman E Avniel A Bentwich I Bentwich Z Cohen D Chajut A Barshack I Micro RNA accurately identify cancer tissue origin Nat Biotechnol 2008, 26:462-469 18362881
40. Michiels S Koscielny S Hill C Prediction of cancer outcome with microarrays: A multiple random validation strategy Lancet 2005, 365:488-492 15705458
41. Irizarry RA Warren D Spencer F Kim IF Biswal S Frank BC Gabrielson E Gracia JG Georghegan J Germino G Griffin C Hilmer SC Hoffman E Jedlicka AE Kawasaki E Martinez-Murillo F Morsberger L Lee H Petersen D Quackensbush J Scott A Wilson M Yang Y Ye SQ Yu W Multiple-laboratory comparison of microarray platforms Nat Methods 2005, 2:345-350 15846361
42. Yauk CL Berndt ML Review of the literature examining the correlation among DNA microarray technologies Environ Mol Mutagen 2007, 48:380-394 2682332 17370338
43. de Reynies A Geromin D Cayuela JM Petel F Dessen P Sigaux F Rickman DS Comparison of the latest commercial short and long oligonucleotide microarray technologies BMC Genomics 2006, 7:51 1473202 16539734
44. Cowell JK Hawthorn L The application of microarray technology to the analysis of cancer genome Curr Mol Med 2007, 7:103-120 17311536
45. Strausberg RL Levy S Rogers YH Emerging DNA sequencing technologies for human genomic medicine Drug Discov Today 2008, 13:569-577 18598911
46. Shendure J Ji H Next-generation DNA sequencing Nat Biotechnol 2008, 26:1135-1145 18846087
47. Speicher MR Carter NP The new cytogenetics: Blurring the boundaries with molecular biology Nat Rev Genet 2005, 6:782-792 16145555
48. Lambros MB Natrajan R Reis-Filho JS Chromogenic and fluorescent in situ hybridization in breast cancer Hum Pathol 2007, 38:1105-1122 17640550
49. Hsi BL Xiao S Fletcher JA Chromogenic in situ hybridization and FISH in pathology Methods Mol Biol 2002, 204:343-351 12397808
50. Kallioniemi A Kallioniemi OP Sudar D Rutoviz D Gray JW Waldman F Pinkel D Comparative genomic hybridization for molecular cytogenetic abnalysis of solid tumors Science 1992, 258:818-821 1359641
51. Maciejewsi JP Mufti GJ Whole genome scanning as a cytogenetic tool in hematologic malignancies Blood 2008, 112:965-974 18505780
52. Mortazavi A Williams BA McCue K Schaeffer L Wold B Mapping and quantifying mammalian transcriptomes by RNA-Seq Nat Methods 2008, 5:621-628 18516045
53. Shendure J The beginning of the end of microarrays? Nat Methods 2008, 5:585-587 18587314
54. Rhoades A Molecular Pathology. Its integration in the routine laboratory The Biomedical Scientist 2006, 8:714-718
55. Camp RL Neumeister V Rimm DL A decade of tissue microarrays: Progress in the discovery and validation of cancer biomarkers J Clin Oncol 2008, 26:5630-5637 18936473
56. Moeder CB Giltnane JM Harigopal M Molinaro A Robison A Gelmon K Huntsman D Camp RL Rimm DL American Society of Clinical Oncology; College of American Pathologists Quantititive justification of the change from 10% to 30% for human EGFR2 scoring in the ASCO/AAP guidelines: Tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome J Clin Oncol 2007, 25:5418-5425 18048824
57. Tomlins SA Rhodes DR Perner S Dhanasekaran SM Mehra R Sun XW Varambally S Cao X Tchinda J Kuefer R Lee C Montjie JE Shah R Pienta KJ Rubin MA Channayan AM Recurrent fusions of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 2005, 310:644-648 16254181
58. Voduc D Kenney C Nielsen TO Tissue microarrays in clinical oncology Semin Radiat Oncol 2008, 18:89-97 2292098 18314063
59. Owens SR Greenson JK Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas Am J Surg Pathol 2007, 31:285-290 17255774
60. Perou CM Sorlie T Eisen MB Rijn van der M Jeffrey SS Rees CA Pollack JK Ross DT Johnsen H Aksien LA Fluge O Pergamenschikov A Williams C Zhu S Lenning P Borresen-Dale A Brown P Botstein D Molecular portraits of human breast cancer Nature 2000 ,406:747-752 10963602
61. Espina V Heiby M Pierobon M Liotta MA Laser capture microdissection technology Expert Rev Mol Diagn 2007, 7:647-657 17892370
62. Rodrigues AS Espina BH Espina V Liotta LA Automated laser capture microdissection for tissue proteomics Methods Mol Biol 2008, 441:71-90 18370312
63. Hergenhahn M Kenzelmann M Grohne HJ Laser-controlled microdissection of tissues opens a window for new opportunities Pathol Res Pract 2003, 199:419-423 12924444
64. Kolch W Mischak H Pitt AR The molecular make-up of a tumor: Proteomics in cancer research Clin Sci (Lond) 2005, 108:369-383 15831087
65. Petrocoin EF Biechsel VE Calvert VS Espina V Winters M Young L Belluco C Trock BJ Lippman M Fishmann D Sgoi DC Munson PJ Esserman LJ Liotta LA Mapping molecular networks using proteomics: A vision for patient-tailored combination therapy J Clin Oncol 2005, 23:3614-3621 15908672
66. Lin J Li M Molecular profiling in the age of cancer genomics Expert Rev Mol Diagn 2008, 8:263-276 18598106
67. Omenn GS Strategies for plasma proteomic profiling of cancers Proteomics 2006, 6:5662-5673 16991194
68. Wulfkuhle J Espina V Liotta L Petricoin E Genomic and proteomic technologies for individualization and improvement of cancer treatment Eur J Cancer 2004, 40:2623-2632 15541963
69. Hager JW Recent trends in mass spectrometer development Anal Bioanal Chem 2004, 378:845-850 14598011
70. Gorelik E Landsittel D Marrangoni A Modugno F Velikokhatnaya L Winans M Bigbee W Herberman R Loksin A Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer Cancer Epidemiol Biomarkers Prev 2005, 14:981-987 15824174
71. Pelech S Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions Curr Pharm Biotechnol 2004, 5:69-77 14965210
72. Frese KK Tuveson DA Maximizing mouse cancer models Nat Rev Cancer 2007, 7:645-658 17687385
73. van Dyke T Jacks T Cancer modeling in the modern era: Progress and challenges Cell 2002, 108:135-144 11832204
74. Hanahan D Wagner EF Palmiter RD The origins of oncomice: A history of the first transgenic mice genetically engineered to develop cancer Genes Dev 2007, 21:2258-2270 17875663
75. Lewis JS Achilefu S Garbow JR Laforest R Welch MJ Small animal imaging. Current technology and perspectives for oncological imaging Eur J Cancer 2002, 38:2173-2188 12387842
76. Weissleder R Scaling down imaging: Molecular mapping of cancer in mice Nat Rev Cancer 2002, 2:11-18 11902581
77. Olive KP Tuveson DA The use of targeted mouse models for preclinical testing of novel cancer therapeutics Clin Cancer Res 2006, 12:5277-5287 17000660
78. Kherlopian AR Song T Duan Q Neimark M Po MJ Gohagan JK Laine AF A review of imaging techniques for system biology BMC Syst Biol 2008, 2:74 2533300 18700030
79. Pittet MJ Mempel TR Regulation of T-cell migration and effector functions: Insights from in vivo imaging Immunol Rev 2008, 221:107-129 18275478
80. Nyman HAT Kristensen AT Flagstad A McEvoy FJ A review of sonographic assessment of tumor metastases in liver and superficial lymph nodes Vet Radiol Ultrasound 2004, 45:438-448 15487569
81. Riegman PH Dinjens WN Oosterhius JW Biobanking for interdisciplinary clinical research Pathobiology 2007, 74:239-244 17709966
82. Morente MM Alonso S Current challenges of human tumor banking Hematol Oncol 2005, 23:54-56 16216033
83. Barnes RO Parisien M Murphy LC Watson PH Influence of evolution in tumor banking on the interpretation of translational research Cancer Epidemiol Biomarkers Prev 2008, 17:3344-3350 19064549
84. International Society for Biological and Environmental Repositories Best practices for repositories I: Collection, storage, and retrieval of human biological materials for research Cell Preservation Technology 2005, 3:5-20
85. van Veen EB Riegman P Dinjens W Lam K Oomen MH Spaz A Mager R Ratcliffe C Knox K Kerr D van damme B vijver van der M van Boven H Morente MM Alonso S kerjaski D Pammer J Lopez-Guerrero J Llombart Bosch A carbone A Gloghini A Teodorovic I Isabelle M Passoiukov A Lejeune S Therasse P Oosterhius JW TuBaFrost3: Regulatory and ethical issues on the exchange of residual tissue for research across Europe Eur J Cancer 2006, 42:2914-2923 17029786
86. Biobanking and Biomolecular Resources Research Infrastructures http://bbmri.eu
87. De Paoli P Biobanking in microbiology: From sample collection to epidemiology, diagnosis and research FEMS Microbiol Rev 2005, 29:897-910 16219511
88. Qualman SJ France M Grizzle WE LiVolsi VA Moskaluk CA Ramirez NC Washington MK Establishing a tumor bank: Banking, informatics and ethics Br J Cancer 2004, 90:1115-1119 15026787
89. Yuille M van Ommen G Brechot C Cambon-Thomsen A Dagher G Landegren U Litton JE Pasterk M Pletonen L Taussig M Wichmann HE Zatloukal K Biobanking in Europe Brief Bioinform 2008, 9:14-24 17959611
90. Pukkala E Andersen A Berglund G Gislefoss R Gudnason V Hallmans G Jellum E Jousilahti P Knekt P Koskela P Kyyronen P Lenner P Loustarinen T Love A Ogsmundottir H Stattin P Tenkanen L Tryggvadottir L Virtamo J Wadell G Widell A Lehtinen M Dillner J Nordic biological specimen banks as basis for studies of cancer causes and control-more than 2 million sample donors, 25 million person years and 100,000 prospective cancers Acta Oncol 2007, 46:286-307 17450464
91. Tedeschi R Luostarinen T De Paoli P Gislefoss RE Tenkanen L Virtamo J Koskela P Hallmans G Lehtinen M Dillner J Joint Nordic prospective study on HHV-8 multiple myeloma risk Br J Cancer 2005, 93:834-837 16136049
92. Knox K Kerr DJ Establishing a national tissue bank for surgically harvested cancer tissue Br J Surg 2004, 91:134-136 14760657
93. Zika E Schulte in der Baumen T Kaye J Brand A Ibarreta D Sample, data use and protection in biobanking in Europe: Legal issues Pharmacogenomics 2008, 9:773-781 18518854
94. Moore JH Bioinformatics J Cell Physiol 2007, 213:365-369 17654500
95. Boguski MS Bioinformatics Curr Opin Genet Dev 1994, 4:383-388 7919915
96. Ermolaeva O Rastogi M Pruitt KD Schuler GD Bittner ML Chen Y Simon R Meltzer P Trent JM Boguski MS Data management and analysis for gene expression arrays Nat Genet 1998, 20:19-23 9731524
97. Kanehisa M Bork P Bioinformatics in the post sequence era Nat Genet 2003, 33(Suppl):305-310 12610540
98. Simon R The use of genomics in clinical trial design Clin Cancer Res 2008, 14:5984-5993 18829477
99. Gomez-Lopez G Valencia A Bioinformatics and cancer research: Building bridges for translational research Clin Transl Oncol. 2008, 10(2):85-95 18258507
100. Nguyen DX Massaguè J Genetic determinants of cancer metastasis Nat Rev Genet 2007, 8:341-352 17440531
101. National Cancer Institute. Cancer Biomedical Informatics Grid https://cabig.nci.nih.gov
102. Anderson KC Setting the standard for translational cancer metastasis Clin Cancer Res 2009, 1:1
103. George SL Statistical issues in translational cancer research Clin Cancer Res 2008, 14:5954-5958 18829473
104. Vickers AJ Jang K Sargent D Lilja H Kattan MW Systematic review of statistical methods used in molecular marker studies in cancer Cancer 2008, 112:1862-1868 2675946 18320601
105. Owzar K Barry WT Jung SH Sohn I George SL Statistical challenges in preprocessing in microarray experiments in cancer Clin Cancer Res 2008, 14:5959-5966 18829474
106. Olopade OI Grusko TA Nanda R Huo D Advances in breast cancer: Pathways to personalized medicine Clin Cancer Res 2008, 14:7988-7999 19088015
107. Tortora G Ciardiello F Gasparini G Combined targeting of EGFR-dependent VEGF-dependent pathways: Rationale, preclinical studies and clinical applications Nat Clin Pract Oncol 2008, 5:521-530 18594498
108. Steeg PS Theodorescu D Metastasis: A therapeutic target for cancer Nat Clin Pract Oncol 2008, 5:206-219 18253104
109. Hurria A Lichtman SM Clinical pharmacology of cancer therapies in older adults Br J Cancer 2008, 98:517-522 18256586
110. Workman P Aboagye E Chung Y Griffiths J Hart R Leach M Maxwell R McSheehy P Prioce P Zweit J Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies J Natl Cancer Inst 2006, 98:580-598 16670384
111. Roses AD Pharmacogenetics in drug discovery and development: A translational perspective Nat Rev Drug Discov 2008, 7:807-817 18806753
112. Yong WP Innocenti F Ratain M The role of pharmacogenetics in cancer therapeutics Br J Clin Pharmacol 2006, 62:35-46 1885075 16842377
113. American Society of Clinical Oncology American Society of Clinical Oncology policy statement. Oversight of clinical research J Clin Oncol 2003, 21:2377-2386 12721281
114. Dilts DM Sandler AB Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials J Clin Oncol 2006, 24:4545-4552 17008693
115. Zwelling LA Brunell CA Strategies for the administration of a clinical trials infrastructure: Lessons from a comprehensive cancer center Cancer Treat Res. 2007, 132:241-274 17305027
116. Moses H Martin JB Academic relationships with industry: A new model for biomedical research JAMA 2001, 285:933-935 11180737
117. Plotkin SA Vaccines: Correlates of vaccine-induced immunity Clin Infect Dis 2008, 47:401-409 18558875
118. Davis MM A prescription for human immunology Immunity 2008, 29:835-838 19100694
119. Hamilton DH Bretscher PA Different immune correlates associated with tumor progression and regression: Implications for prevention and treatment of cancer Cancer Immunol Immunother 2008, 57:1125-1136 18188562
120. Chaussabel D Quinn C Shan J Patel P Glaser C Baldwin N Stichweh D Blankenship D Li L Munagala I Bennett L Allantaz F Mejas A Ardura M Kaizer E Monnet L Allman W Randall H Johnson D Lanier A Punaro M Wittkowski K Whiote P Fay J Klintmalm G Ramilo O Palucka AK Banchereau J Pascual V A modular analysis framework for blood genomic studies:aPplication to systemic lupus erythematosus Immunity 2008, 29:150-164 18631455
121. Heng TS Painter MW The Immunological Genome Project: Networks of gene expression in immune cells Nat Immunol 2008, 9:1091-1094 18800157
122. Girnita DM Burkart G Zeevi A Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation Curr Opin Immunol 2008, 20:614-625 18706500
123. Zak DE Aderem A System biology of innate immunity Immunol Rev 2009, 227:264-282 2697920 19120490
124. Gee AP Regulatory issues in cellular therapies Expert Opin Biol Ther 2003, 3:537-540 12831359
125. Federal Drug and Administration http://www.fda.gov
126. European Commission Enterprise and Industry. Pharmaceuticals. Eudralex http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol4_en.htm
127. Rebulla P Lecchi L Lazzari L Giordano R Porretti L Giovanelli S Salvaterra E Clerici L Baldocchi G Development of a biological resource center for cellular therapy and biobanking in a public polyclinic university hospital Biologicals 2008, 36:79-87 18262794
128. McKenna DH Kadidio DM Miller JS Orchard P Wagner J McCullogh J The Minnesota Molecular and Cellular Therapeutics Facility: A state of the art biotherapeutics engineering laboratory Transfus Med Rev 2005, 19:217-228 16010652
129. STTARR. Spatio-Temporal Targeting and Amplification of Radiation Response http://www.sttarr.ca
130. Liu SK Olive PL Bristow R Biomarkers of DNA DSB inhibitors and radiotherapy in clinical trials Cancer Metastasis Rev 2008, 27:445-458 18516501